Palvella Therapeutics, Inc. (PVLA) Operating income 2016–2025
Palvella Therapeutics, Inc. (PVLA) annual operating income history from SEC filings — each fiscal year as reported.
-$38.6MFY2025 · since FY2016: -$22.8M → -$38.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$38.6M | -173.9% |
| FY2024 | -$14.1M | -18.8% |
| FY2023 | -$11.9M | +72.7% |
| FY2022 | -$43.5M | +16.1% |
| FY2021 | -$51.8M | -52.8% |
| FY2020 | -$33.9M | -24.9% |
| FY2019 | -$27.2M | +11.9% |
| FY2018 | -$30.8M | -111.3% |
| FY2017 | -$14.6M | +35.9% |
| FY2016 | -$22.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PVLA financial trends
PVLA RevenuePVLA Net incomePVLA Net marginPVLA Gross profitPVLA Gross marginPVLA Operating marginPVLA Operating cash flowPVLA Free cash flowPVLA Capital expendituresPVLA Return on equityPVLA Stock buybacksPVLA Dividends paidPVLA Total assetsPVLA Total liabilitiesPVLA Shareholders’ equityPVLA overview →